The significance of cerebral atrophy for the symptomatology of Parkinson's disease
- PMID: 479910
- DOI: 10.1016/0022-510x(79)90050-9
The significance of cerebral atrophy for the symptomatology of Parkinson's disease
Abstract
Hitherto published results on the impact of brain atrophy on the neurological and psychopathological sympion of this problem without risk of complications. We investigated 173 parkinsonian patients (89 men, 84 women) aged 37--83 years. Besides CT in all patients a standardized neurological and psychopathological investigation was carried out, including psychological tests, intelligence, personality structure, fine motor performance and visual reaction times. The investigations revealed pronounced correlations between CT-findings and more severe clinical symptomatology and a corresponding impairment in daily activities in the levodopa-treated and particularly in the untreated group, above all when there was a combination of cortical atrophy and ventricular enlargement. The same was true for fine motor performance and simple and complex reaction times. These functions were more impaired in patients with brain atrophy, irrespective of its localisation, whether cortical atrophy or ventricular enlargement. In contrast, no statistically significant relationship between the different parameters of brain atrophy and intelligence could be found. Considering cortical atrophy as a specific sign in Parkinson's disease -- our results are in favour of this assumption -- and ventricular enlargement more related to increasing age, parkinsonism is influenced by extranigral lesions inherent in the disease and dependent on increasing age.
Similar articles
-
Cerebral atrophy and long-term response to levodopa in Parkinson's disease.J Neurol. 1979;222(1):37-43. doi: 10.1007/BF00313265. J Neurol. 1979. PMID: 93625
-
Relationship between arteriosclerosis and cerebral atrophy in Parkinson's disease.J Neurol. 1977 Dec 1;217(1):11-6. doi: 10.1007/BF00316312. J Neurol. 1977. PMID: 75248
-
The course of brain atrophy in Parkinson's disease.Arch Psychiatr Nervenkr (1970). 1979 Jul 4;227(1):89-95. doi: 10.1007/BF00585681. Arch Psychiatr Nervenkr (1970). 1979. PMID: 496620
-
Intellectual dysfunction and dementia in Parkinson disease.Adv Neurol. 1983;38:211-27. Adv Neurol. 1983. PMID: 6351560 Review. No abstract available.
-
[Clinical criteria of Parkinson's disease].Ther Umsch. 2007 Jan;64(1):5-8. doi: 10.1024/0040-5930.64.1.5. Ther Umsch. 2007. PMID: 17221818 Review. German.
Cited by
-
Cerebral atrophy in Parkinson's disease--represented in CT.Arch Psychiatr Nervenkr (1970). 1979 Jul 4;227(1):81-8. doi: 10.1007/BF00585680. Arch Psychiatr Nervenkr (1970). 1979. PMID: 496619
-
Computed tomography brain changes in parkinsonian dementia.Neuroradiology. 1987;29(6):535-9. doi: 10.1007/BF00350436. Neuroradiology. 1987. PMID: 3431698
-
Cerebral atrophy and long-term response to levodopa in Parkinson's disease.J Neurol. 1979;222(1):37-43. doi: 10.1007/BF00313265. J Neurol. 1979. PMID: 93625
-
Treatment of Parkinson's disease: problems with a progressing disease.J Neural Transm. 1981;51(1-2):161-74. doi: 10.1007/BF01664013. J Neural Transm. 1981. PMID: 7264627
-
Magnetic resonance imaging in dementia of Parkinson's disease.J Neurol Neurosurg Psychiatry. 1989 Nov;52(11):1221-7. doi: 10.1136/jnnp.52.11.1221. J Neurol Neurosurg Psychiatry. 1989. PMID: 2592966 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources